Product
ALN-TTR02
1 clinical trial
1 indication
Indication
TTR-mediated AmyloidosisClinical trial
A Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety, Clinical Activity, and Pharmacokinetics of ALN-TTR02 in Patients With Familial Amyloidotic Polyneuropathy Who Have Previously Received ALN-TTR02Status: Completed, Estimated PCD: 2016-07-01